ADIPOQ and lung disorder: This hypothesis is in accordance with evidence that leptin and adiponectin have a role in regulating Th17 and Th2 immune responses in lung diseases [95,97,139,140], in addition to the expression of pro-inflammatory cytokines and NLRP3 activity, as previously discussed [109,110].